Navigation Links
Phase I Pro-Vas® Effectiveness Study Presented at AUA Meeting
Date:6/8/2011

WASHINGTON, June 8, 2011 /PRNewswire/ -- A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas® occlusion as a highly promising method of permanent male sterilization.

The clinical study results were presented by Douglas A. Swartz, M.D., to a physician audience at the AUA Annual Meeting. The AUA meeting is the world's largest gathering of urologists each year. Dr. Swartz is a private-practice urologist in Jacksonville, Fla. He served as lead investigator for the 15-month clinical study that involved 29 patients.

Dr. Swartz said the Pro-Vas technique is the least invasive – and most effective – form of vasectomy available to men today.

More than 500,000 vasectomies are performed annually in the United States. Traditional vasectomy involves the cutting and cauterizing of both sperm ducts, which causes pain and swelling post surgery. The new Pro-Vas occlusion technique studied by Dr. Swartz, on the other hand, utilizes an easy-to-apply, titanium spring ligation clip that stops the flow of sperm without the need to cut or burn the sperm ducts.

In addition to its initial high effectiveness rate, Pro-Vas also was noted to result in less post-procedure pain and quicker return to normal activities compared with traditional vasectomy. Additionally, there were no complications following Pro-Vas occlusions, but it is acknowledged the number of patients is not sufficient to provide statistically significant results.

"The Pro-Vas occlusion technique has the potential to simplify and standardize the vasectomy technique," Dr. Swartz said. "It may provide less experienced vasectomy surgeons a means for achieving clinical results similar to those of experienced surgeons. The Pro-Vas technique also spares sacrificing the vasal artery."

Dr. Swartz added that there should be a lower recanalization rate with the Pro-Vas method because the spring ligat
'/>"/>

SOURCE MenRx Surgical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... BOULDER, Colo. , April 27, 2015 ... will report financial results for the third ... conference call to discuss those results on ... Executive Officer will lead the call.Date:Monday, May ... Code: 5249676 Webcast, including Replay and Conference ...
(Date:4/27/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that it has received a close-out ... ("FDA") verifying that the Company has successfully implemented corrective ... received from the FDA in January 2013. ... by the FDA at CryoLife,s manufacturing facility and headquarters ...
(Date:4/27/2015)... NEW YORK , April 27, 2015   ... management solutions, will showcase advances in monitored care that ... the upcoming ATA 2015 Conference, May 2-5 ... Center. AMC Health will share information about ... monitored care to help transform and personalize healthcare delivery ...
Breaking Medicine Technology:CryoLife Announces Resolution of FDA Warning Letter 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4
... DIEGO, Oct. 13 RESMED INC. (NYSE: RMD ... will release its results for the first quarter of fiscal ... ResMed,s results will be issued after 1:00 p.m. Pacific Time ... to review its results, market trends, and future outlook. ...
... Care Continuum Alliance honored Kaiser Permanente,s ALL/PHASE initiative ... on Health" at The Forum 10 conference ... low-cost and generic medications and clinical interventions to reduce ... communities, including those served by safety net organizations. ...
Cached Medicine Technology:ResMed Announces Conference Call and Webcast to Discuss First Quarter 2011 Results 2Kaiser Permanente's ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health 2Kaiser Permanente's ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health 3
(Date:4/28/2015)... Henderson, NV (PRWEB) April 28, 2015 ... University's Center for Ethics (June 27, 2014), prescription ... the world. Medical Science is becoming increasingly aware of ... on the market, such as chemotherapy drugs to treat ... bacteria that are quickly evolving to become increasingly resistant ...
(Date:4/28/2015)... 2015 Foot and Ankle Specialists ... D. Palmer ( Annapolis and Clarksville Divisions ) ... at the Maryland Podiatric Medical Association meeting on April ... University in 1992 with a Bachelor of Arts in ... in intercollegiate soccer, track and cross-country. He then attended ...
(Date:4/27/2015)... 2015 Churchview Supportive Living, a Gardant ... Brunch and Fashion Show from 10:30 a.m. to noon ... at 2626 W. 63rd St. in Chicago, serves low-income ... help to maintain their independence. , “Mothers, grandmothers, godmothers ... Mother’s Day Brunch,” said Director of Marketing Elizabeth Clippard. ...
(Date:4/27/2015)... April 28, 2015 Healthcare marketing ... paper called “Website Anatomy 101.” Available ... the necessary design elements for a successful hospital ... responsive design, user experience, search results and lead ... of a well-designed website on patient volume and ...
(Date:4/27/2015)... A variety of events are planned to support ... abuse. Programming for Jericho for boys is being enhanced this ... summer. , The first event is a sellout golf tournament ... Youth Town Jim Jackson Golf Classic will be held at ... tee times at 8 a.m. and 1 p.m. Team sponsorships ...
Breaking Medicine News(10 mins):Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 2Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 4Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives Maryland Podiatric Medical Association Outstanding Service Award 2Health News:Churchview Supportive Living Community in Chicago to Host Mother's Day Brunch 2Health News:Smith & Jones Publishes 2015 Website Design White Paper 2Health News:Golf, Sermon on the Mount and More to Support Youth Town’s Jericho and Eden Programs 2
... Feb. 20 LifeSync Corporation is,pleased to announce ... Vice,President of Research and Development. Dr. Phelps, who ... be responsible for leading all,product design and development ... the Georgia Electronic Design Center (GEDC),at the Georgia ...
... Holmes,today announced that, due to continuing declines in Portamedic ... the fourth quarter 2007,excluding the gain on sale of ... part to a greater than expected,reduction in paramedical exams ... prior year. Regarding 2008, the Company no longer expects ...
... dermal filler market is expected to grow at a compound ... to Millennium Research Group, WALTHAM, Mass., Feb. 20 ... Aesthetic,Orthopedic, and Emerging Applications 2008 report, the US hyaluronic acid,(HA) ... rate of,nearly 20% from 2006 through 2011., Growth in ...
... YUCAIPA, Calif., Feb. 20 Ingen Technologies,Inc. ... manufacturer, announced,today that the Taiwan registration process ... International Holding Company,Ltd., has been initiated. Progressive ... Taipei Economic and Cultural Representative,Office in the ...
... Erbitux Will Earn Gold-Standard Status in 2011, ... to a New Report from Decision Resources, WALTHAM, ... leading research and advisory firms focusing on pharmaceutical and,healthcare ... is the,attribute that most influences oncologists, prescribing decisions in ...
... -- China Dongsheng,International, Inc. (OTC Bulletin Board: CDSG), ... personal care products provider,in China, today announced the ... quarter ended December 31, 2007., -- ... its own branded products ...
Cached Medicine News:Health News:LifeSync Hires Dr. Mark Phelps to Lead Research & Development 2Health News:Hooper Holmes Updates Guidance 2Health News:Hooper Holmes Updates Guidance 3Health News:Hyaluronic Acid Dermal Filler Market Skyrockets 2Health News:-Ingen Technologies Registers Oxyview(R) in Taiwan- 2Health News:-Ingen Technologies Registers Oxyview(R) in Taiwan- 3Health News:In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer 2Health News:China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 2Health News:China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 3Health News:China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 4Health News:China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 5Health News:China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 6
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
... Type 14, 14A and 14C have been approved. ... to accommodate the variations in the size of ... tension rings are designed to stabilize the capsule ... large panel of U.S. ophthalmologists. For implatations ...
... is a device designed for permanent implantation ... removal surgery. It provides secondary capsular bag ... The CTR is a uniplanar, 270-degree, semi-circle ... absorbing polymethylmethacrylate (PMMA) with one manipulation eyelet ...
Stainless steel cartilage scissors....
Medicine Products: